View Post

Bisexual and Gay Men Benefit from HPV Vaccination

In COVID-19, Latest News by Precision Vaccinations

A new study led by Monash University and Alfred Health found a 70% reduction in one type of human papillomavirus (HPV) in gay and bisexual men after the implementation of an HPV vaccination program in 2013.
Published in Lancet Infectious Diseases on May 24, 2021, the HYPER2 study found a significant reduction in vaccine-preventable HPV genotypes in men who have sex with men (MSM) aged 16-20 years following the introduction of the vaccine.
And the decrease in anal HPV 16 and 18 may lead to a reduction in the incidence of anal cancer.